Answers to common questions about the MedCore portfolio, product documentation, research evidence, certificates, regulatory context and the purpose of this website.
Questions are grouped around the information visitors most often need to interpret the MedCore site correctly.
MedCore Peptides is presented on this website as a research-focused product information brand. The site organizes compound identity, product presentation, research context, quality documentation and responsible information boundaries in dedicated product profiles.
No. The current MedCore website is a company and product-information platform and does not provide direct online checkout.
No such blanket claim should be made. Some active substances may have approved medicine contexts, while other compounds remain investigational. The regulatory status of an active substance does not automatically establish the status of a specific MedCore presentation. Product pages should state the relevant context carefully.
It means the site is structured around product identity, research literature, regulatory context and documentation rather than consumer treatment claims. It does not mean that a “research use” label overrides the legal or regulatory significance of how a product is otherwise presented.
The site is prepared to publish verified COAs, analytical reports, batch records and other product-specific documentation when supplied. Each document should be linked to the exact product and, where applicable, matching batch reference.
No. A COA or analytical certificate reports information about a tested sample or batch. A clinical study evaluates outcomes in human research. One should never be presented as a substitute for the other.
No. Analytical documentation may support sample identity, purity or another reported test parameter, depending on the document. It does not by itself establish clinical efficacy, safety, approved use, dosage or prescribing suitability.
Where the compound and research entity are the same, multiple MedCore strengths are consolidated on one canonical product profile. This reduces duplicate content and keeps research, regulatory and documentation context connected to the same compound entity.
Primary and authoritative sources are preferred when available, including official regulatory databases, registered clinical-trial records and peer-reviewed biomedical literature. Secondary summaries may provide context but should not replace the source closest to the claim.
No. The MedCore website does not provide patient-specific dosing, administration, treatment or prescribing instructions. Medical decisions should rely on qualified healthcare professionals and the authorized information applicable to the exact medicine and jurisdiction.
Read it as contextual information that should be checked against the current official authority relevant to the exact active substance, finished product and jurisdiction. Regulatory status can change and should not be inferred from research activity or analytical documentation.
Use the dedicated Pharmacy & Prescriber page, then continue to the exact product profile and its supporting evidence or documentation.
The Research & Evidence page explains the distinction between identity, preclinical research, human studies, clinical trials, regulatory status and product-specific analytical documentation.
It should not be presented as established evidence. The MedCore content model is designed to prefer a visible limitation over an unsupported claim.
That combination is the intended way to use the MedCore information architecture.
